Ultraviolet light protection by several new compounds.
D000287:Administration, Topical; D062365:Aminobenzoates / Q000494:pharmacology; D000873:Anthracenes / Q000494:pharmacology; D000975:Antioxidants / Q000009:adverse effects / Q000494:pharmacology*; D001966:Bromine / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004260:DNA Repair / Q000187:drug effects*; D003877:Dermatitis, Contact / Q000209:etiology; D004912:Erythrocytes / Q000187:drug effects; D005707:Gallic Acid / Q000494:pharmacology*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008027:Light / Q000009:adverse effects; D010100:Oxygen / Q000097:blood; D011166:Porphyrins / Q000494:pharmacology; D011831:Radiation Genetics / Q000187:drug effects*; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D012457:Salicylamides / Q000494:pharmacology; D012867:Skin / Q000187:drug effects; D013053:Spectrophotometry; D013936:Thymidine / Q000494:pharmacology; D014466:Ultraviolet Rays / Q000009:adverse effects; D000338:beta-Aminoethyl Isothiourea / Q000494:pharmacology
D062365:Aminobenzoates; D000873:Anthracenes; D000975:Antioxidants; D002090:Butyrophenones; D011166:Porphyrins; D011837:Radiation-Protective Agents; D012457:Salicylamides; D000338:beta-Aminoethyl Isothiourea; D005707:Gallic Acid; D010100:Oxygen; D001966:Bromine; D002746:Chlorpromazine; D013936:Thymidine